Value-based health care in heart failure: Quality of life and cost analysis.

Autor: Ghisleni EC; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Post-Graduate Program in Cardiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Astolfi VR; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Zimmermann L; Faculdade de Medicina, Universidade Luterana do Brasil, Canoas, RS, Brazil; Hospital Universitário de Canoas, Canoas, RS, Brazil., Lira CNL; Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil., Faria do Nascimento E; Faculdade de Medicina, Universidade Luterana do Brasil, Canoas, RS, Brazil., Etges APBDS; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; National Institute of Science and Technology for Health Technology Assessment (IATS) ‒ CNPq/Brazil (project: 465518/2014-1), RS, Brazil; Faculdade de Tecnologia, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil; Post-Graduation Program in Epidemiology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil., Marcondes-Braga FG; Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil., Bacal F; Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Danzmann LC; Faculdade de Medicina, Universidade Luterana do Brasil, Canoas, RS, Brazil; Hospital Universitário de Canoas, Canoas, RS, Brazil., Polanczyk CA; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; National Institute of Science and Technology for Health Technology Assessment (IATS) ‒ CNPq/Brazil (project: 465518/2014-1), RS, Brazil; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil., Biolo A; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Post-Graduate Program in Cardiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: biolo.andreia@gmail.com.

Publikováno v: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2023 Oct 28; Vol. 78, pp. 100294. Date of Electronic Publication: 2023 Oct 28 (Print Publication: 2024).

Author Correction: Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial.

Autor: Piardi DS; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Butzke M; Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Porto Alegre, 90035-003, Brazil., Mazzuca ACM; Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Porto Alegre, 90035-003, Brazil., Gomes BS; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Alves SG; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Kotzian BJ; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Ghisleni EC; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Giaretta V; Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Porto Alegre, 90035-003, Brazil., Bellaver P; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.; Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Porto Alegre, 90035-003, Brazil., Varaschin GA; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Garbin AP; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Beck-da-Silva L; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. lbneto@hcpa.edu.br.; Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Porto Alegre, 90035-003, Brazil. lbneto@hcpa.edu.br.

Publikováno v: Scientific reports [Sci Rep] 2021 Aug 24; Vol. 11 (1), pp. 17370. Date of Electronic Publication: 2021 Aug 24.

HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.

Autor: da Cunha Jaeger M; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute, Porto Alegre, RS, Brazil., Ghisleni EC; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Cardoso PS; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Siniglaglia M; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute, Porto Alegre, RS, Brazil., Falcon T; Bioinformatics Core, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Brunetto AT; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute, Porto Alegre, RS, Brazil., Brunetto AL; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute, Porto Alegre, RS, Brazil., de Farias CB; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute, Porto Alegre, RS, Brazil., Taylor MD; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada., Nör C; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada., Ramaswamy V; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Roesler R; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil. rafaelroesler@hcpa.edu.br.; Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500 (ICBS, Campus Centro/UFRGS), Porto Alegre, RS, 90050-170, Brazil. rafaelroesler@hcpa.edu.br.

Publikováno v: Journal of molecular neuroscience : MN [J Mol Neurosci] 2020 Jun; Vol. 70 (6), pp. 981-992. Date of Electronic Publication: 2020 Feb 13.

Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.

Autor: Jaeger M; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Ghisleni EC; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Fratini L; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Brunetto AL; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute (ICI), Porto Alegre, RS, Brazil., Gregianin LJ; Department of Pediatrics, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Brunetto AT; Children's Cancer Institute (ICI), Porto Alegre, RS, Brazil., Schwartsmann G; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Department of Internal Medicine, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., de Farias CB; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Children's Cancer Institute (ICI), Porto Alegre, RS, Brazil., Roesler R; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil. rroesler@terra.com.br.; Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500 (ICBS, Campus Centro/UFRGS), Porto Alegre, RS, 90050-170, Brazil. rroesler@terra.com.br.

Publikováno v: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2016 Jan; Vol. 32 (1), pp. 61-4. Date of Electronic Publication: 2015 Nov 20.